What is Paperplane Therapeutics?
Paperplane Therapeutics is at the forefront of developing immersive virtual reality (VR) solutions aimed at mitigating pain and anxiety for patients undergoing medical procedures. Their clinically validated therapies are designed for both healthcare and dental care settings, offering a non-pharmacological alternative that is both accessible and cost-effective. The company is committed to enhancing patient outcomes through strategic alliances with leading medical institutions and a foundation of rigorous scientific research. By prioritizing user-friendly interfaces, Paperplane Therapeutics empowers healthcare professionals to integrate these innovative VR treatments seamlessly into their existing practice frameworks, marking a significant advancement in patient care technology.
How much funding has Paperplane Therapeutics raised?
Paperplane Therapeutics has raised a total of $1.5M across 1 funding round:
Other Financing Round
$1.5M
Other Financing Round (2025): $1.5M with participation from Centre for Aging and Brain Health Innovation and Investissement Quebec
Key Investors in Paperplane Therapeutics
Centre for Aging and Brain Health Innovation
The Centre for Aging and Brain Health Innovation (CABHI) is a key player in advancing solutions for the aging population, focusing on innovation in brain health and providing support for scaling technologies in this critical sector.
Investissement Quebec
Investissement Quebec is a provincial financial institution dedicated to fostering economic development and job creation within Quebec by providing businesses with a comprehensive suite of financial solutions.
What's next for Paperplane Therapeutics?
The substantial enterprise-level backing and recent strategic investment position Paperplane Therapeutics for accelerated growth and market penetration. This capital infusion is expected to fuel further research and development, potentially expanding the therapeutic applications of their VR technology. The company's focus on partnerships with major healthcare providers suggests a strategy geared towards scaling operations and solidifying its market presence. Future endeavors will likely involve broader clinical validation and the integration of their solutions into more diverse medical environments, reinforcing their role as a key player in the digital therapeutics space.
See full Paperplane Therapeutics company page
